Market Tracker

08/29 4:12pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.51
Data as of 3:57pm ET
 +0.21 / +3.96%
Today’s Change
3.10
Today|||52-Week Range
7.45
+3.38%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close5.30
Today’s open5.30
Day’s range5.27 - 5.51
Volume865,267
Average volume (3 months)1,437,185
Market cap$368.6M
Dividend yield--
Data as of 3:57pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)+25.49%
Earnings growth (this year)+63.16%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-44.03%
P/E ratioNM
Price/Sales37.83
Price/Book4.08

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...+0.04+2.90%
SUPNSupernus Pharmaceuti...+0.26+2.95%
SGYPSynergy Pharmaceutic...+0.11+2.91%
IGIGI Laboratories Inc+0.10+1.47%
Data as of 3:57pm ET, 08/29/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$7.9M
Annual profit (last year)-$42.6M
Net profit margin-541.49%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer, Treasurer, CAO &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts